首页> 美国卫生研究院文献>Journal of Arrhythmia >Use of simplified HAS‐BLED score in patients with atrial fibrillation receiving warfarin

【2h】

Use of simplified HAS‐BLED score in patients with atrial fibrillation receiving warfarin

机译：简化的HAS-BLED评分在接受华法令的房颤患者中的应用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundOral anticoagulant drugs are proven to prevent thromboembolism in patients with atrial fibrillation (AF). To date, HAS‐BLED score is used to assess bleeding risk. This study was conducted to compare simplified HAS‐BLED (sHAS‐BLED) with conventional HAS‐BLED (cHAS‐BLED) scores.

机译：背景技术口服抗凝药物已被证明可预防房颤（AF）患者的血栓栓塞。迄今为止，HAS-BLED评分用于评估出血风险。本研究旨在比较简化的HAS-BLED（sHAS-BLED）与常规HAS-BLED（cHAS-BLED）得分。

著录项

期刊名称 Journal of Arrhythmia
作者
Komsing Methavigul; Ratikorn Methavigul;
展开▼
作者单位

展开▼
年(卷),期 2019(35),5
年度 2019
页码 711–715
总页数 5
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
labile INR poor anticoagulation control SAMe‐TT2R2 simplified HAS‐BLED time in therapeutic range;

机译：INR不稳定;抗凝控制不佳;SAMe‐TT2R2;简化的HAS‐BLED;治疗范围内的时间;

相似文献

外文文献
中文文献
专利

1. Use of simplified HAS‐BLED score in patients with atrial fibrillation receiving warfarin [J] . Komsing Methavigul, Ratikorn Methavigul Journal of arrhythmia. . 2019,第5期

机译：简化的HAS-BLED评分在接受华法令的房颤患者中的应用
2. Performance of the HEMORR 2HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: The AMADEUS (Evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study [J] . ApostolakisS., LaneD.A., GuoY., Journal of the American College of Cardiology . 2012,第9期

机译：在接受抗凝治疗的房颤患者中，HEMORR 2HAGES，ATRIA和HAS-BLED出血风险预测评分的表现：AMADEUS（评估房颤患者中与华法林或乙酰香豆酚相比，SR34006的使用）
3. Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial [J] . Senoo Keitaro, Lip Gregory Y. H. International Journal of Cardiology . 2016,第Null期

机译：非华法林抗凝性房颤患者中HAS-BLED和ORBIT出血风险评分的预测能力：一项AMADEUS试验的辅助分析
4. Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients [C] . Shijing Guo, Xiang Li, Xin Du, MEDINFO . 2017

机译：基于组的术语轨迹分析，用于高级患者的华法林治疗
5. Cost effectiveness of warfarin in anticoagulant clinic after introduction of dabigatran for stroke prevention in atrial fibrillation patients in the United States [D] . Alhazami, Mai S. 2015

机译：在美国引入达比加群后预防心房颤动患者中风后华法林在抗凝临床中的成本效益
6. Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation [O] . Koji Ono, Makoto Iwama, Masanori Kawasaki, 2012

机译：CHADS2评分低且接受华法令治疗的持续性非瓣膜性心房颤动患者的左心耳运动是血栓形成的决定因素
7. Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation The AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) Study [O] . Apostolakis Stavros, Lane Deirdre A., Guo Yutao, 2012

机译：接受抗凝治疗的房颤患者中HEMORR2HAGES，心房和HAS-BLED出血风险预测评分的表现AMADEUS（评估房颤患者中与华法林或乙酰甲香酚相比，SR34006的使用）

Use of simplified HAS‐BLED score in patients with atrial fibrillation receiving warfarin

摘要

著录项

相似文献

相关主题

期刊订阅